Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Defense was posted on April 9, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

ATROPINE SULFATE IN

Closed
SPE2DP-26-T-2778Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

This contract covers the procurement of Atropine Sulfate Injection, USP, supplied as a sterile, nonpyrogenic, preservative-free 5 mL single-dose syringe with a concentration of 0.1 mg/mL, totaling 0.5 mg per syringe. The injection is designed for subcutaneous, intramuscular, or intravenous administration and includes a male Luer lock adapter with a protected needle sized 20 gauge by 1.5 inches. The product is free of DEHP and contains sodium chloride to maintain isotonicity. Packaging and labeling must comply with medical marking standards and Defense Logistics Agency (DLA) technical and quality requirements, with a shelf life of 24 months under controlled room temperature storage conditions. The contract specifies delivery to a military facility at Fort Bragg, North Carolina, with a required delivery timeline of 20 days and zero tolerance for quantity variation. Inspection and acceptance are to occur at the destination. All packaging must adhere to DLA packaging standards and federal regulations regarding hazardous materials, if applicable. The contract is managed by the Department of Defense’s Medical Supply Chain and requires coordination with designated points of contact. The solicitation and award processes follow DLA master list technical requirements and include referral to product specialists for confirmation, ensuring compliance with FDA regulations and government marking standards.

General Info

Procure sterile Atropine Sulfate 0.5 mg syringes, deliver to Fort Bragg within 20 days.

NAICS

423450 - Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

Place of Performance

5234 EAGLE TALON DR BLDG X3063, FORT BRAGG, NC, 28310, USA

Set-Aside

NONE

Documents

1

SPE2DP-26-T-2778.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA

Full Description

Show more
ATROPINE SULFATE IN
ATROPINE SULFATE INJECTION,USP
RX ONLY. SUPPLIED WITH SINGLE-DOSE UNIT OF
USE SYRINGE WITH MALE LUER LOCK ADAPTER AND
PROTECTED NEEDLE. MAY BE ADMINISTERED
SUBCUTANEOUSLY, INTRAMUSCULARLY OR
INTRAVENOUSLY. STERILE AND NONPYROGENIC.
NON-DEHP, PRESERVATIVE-FREE. SIZE: 5 ML.
CONCENTRATION: 0.1 MG/ML. TOTAL
CONTENT (ATROPINE): 0.5 MG/5 ML. SYRINGE
DIMENSIONS: 20 G (GAUGE) X 1.5". EACH
MILLILITER (ML) CONTAINS ATROPINE SULFATE,
MONOHYDRATE 0.1 MG (ADULT STRENGTH) AND
SODIUM CHLORIDE, 9 MG.
.
1 PG = 10 EA
.
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item. . STORE AT CONTROLLED ROOM TEMPERATURE 20° TO 25°C (68° TO 77°F) [SEE USP CONTROLLED ROOM TEMPERATURE]. . RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS (IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
. MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO contact@example.gov. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/ . This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. .
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
PFIZER INC 86491 P/N NDC00409-4910-34
SPE2DP-26-T-2778
SECTION B
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016247003 0001 PG 1.000
NSN/MATERIAL:6505015731657
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
BULK BREAK POINT:
W91KBP
0003 SF BN 01 CO A SUSTAINMEN
3D SFG SSA AWCF SSF
5234 EAGLE TALON DR BLDG X3063
FORT BRAGG NC 28310
US
SHIP BY TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
W91KBP
0003 SF BN 01 CO A SUSTAINMEN
3D SFG SSA AWCF SSF
5234 EAGLE TALON DR BLDG X3063
FORT BRAGG NC 28310
US
SPE2DP-26-T-2778
SECTION B
PR: 7016247003 PRLI: 0001 CONT’D
MARKFOR
W91KBP
0003 SF BN 01 CO A SUSTAINMEN
3D SFG SSA AWCF SSF
5234 EAGLE TALON DR BLDG X3063
FORT BRAGG NC 28310
US
M/F: (TCN) W91KBP60970132
RDD: 108
PROJ: TP 3
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 12
DIC: A0A DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:04/10/2026
SPE2DP-26-T-2778 NSN/Part Number: 6505-01-573-1657 Quantity: 1 PG Purchase Request: 7016247003QTY: 1 Delivery: 20 days ADO

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 423450
New
DIBBS
SODIUM CHLORIDE INJECT
Solicitation # SPE2DP-27-T-0167
Solicitation SPE2DP-27-T-0167 is a Request for Quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Sodium Chloride Injection. The required product consists of 10 ML preservative-free, latex-free dispensing syringes, packaged in trays of 30 syringes per unit of issue. This FDA-regulated drug is classified as a Type I Code M item with a non-extendable shelf life of 24 months. The solicitation includes multiple contract line items for delivery to various locations, including Fort Bliss, Texas, and Fort Bragg, North Carolina, with a required delivery period of 20 days and an original required delivery date of October 27, 2026. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and requires commercial packaging per ASTM D3951 for non-hazardous materials or TQ requirement IP025 for hazardous materials. Palletization must comply with DLA packaging requirement RP001. Terms are FOB Destination, with inspection and acceptance also occurring at the destination. Offerors must submit quotes via the DIBBS system and are encouraged to provide quantity ranges. This acquisition is not a small business set-aside and falls under NAICS code 423450. Payment and invoicing are to be processed electronically through the Wide Area WorkFlow system.
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

about 20 hours ago

DEADLINE

in 5 days
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS